Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts Sells 900 Shares

Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts sold 900 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $298.55, for a total value of $268,695.00. Following the completion of the transaction, the executive vice president now owns 65,314 shares in the company, valued at approximately $19,499,494.70. This represents a 1.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Johanna Roberts also recently made the following trade(s):

• On Thursday, April 24th, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $300.01, for a total transaction of $180,006.00.
• On Tuesday, April 1st, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $269.11, for a total value of $161,466.00.
• On Monday, March 3rd, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $287.43, for a total transaction of $172,458.00.

Penumbra Trading Down 4.5%

Shares of PEN opened at $275.95 on Friday. Penumbra, Inc. has a fifty-two week low of $148.00 and a fifty-two week high of $310.00. The business has a 50-day moving average of $279.00 and a 200 day moving average of $262.86. The firm has a market cap of $10.69 billion, a P/E ratio of 811.62, a price-to-earnings-growth ratio of 2.83 and a beta of 0.53. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.25 and a current ratio of 6.01.

Penumbra (NYSE:PEN) last issued its earnings results on Wednesday, April 23rd. The company reported $0.83 earnings per share for the quarter, topping analysts’ consensus estimates of $0.66 by $0.17. Penumbra had a net margin of 1.17% and a return on equity of 9.74%. The firm had revenue of $324.14 million during the quarter, compared to analyst estimates of $315.72 million. During the same quarter last year, the business earned $0.41 earnings per share. The company’s quarterly revenue was up 16.3% on a year-over-year basis. As a group, research analysts forecast that Penumbra, Inc. will post 3.67 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on PEN. Needham & Company LLC restated a “hold” rating on shares of Penumbra in a report on Wednesday, February 19th. Truist Financial boosted their target price on Penumbra from $315.00 to $330.00 and gave the stock a “buy” rating in a research note on Thursday, April 24th. Wells Fargo & Company lifted their price target on Penumbra from $305.00 to $315.00 and gave the stock an “overweight” rating in a report on Thursday, April 24th. Bank of America began coverage on Penumbra in a research report on Friday, March 14th. They issued a “buy” rating and a $320.00 price objective on the stock. Finally, Stifel Nicolaus set a $318.00 target price on Penumbra and gave the company a “buy” rating in a research report on Thursday, April 24th. Three research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $302.40.

Institutional Investors Weigh In On Penumbra

Several institutional investors have recently made changes to their positions in PEN. PDT Partners LLC raised its stake in shares of Penumbra by 30.8% during the 1st quarter. PDT Partners LLC now owns 15,076 shares of the company’s stock valued at $4,031,000 after purchasing an additional 3,546 shares during the period. Royal Bank of Canada increased its position in shares of Penumbra by 35.8% during the first quarter. Royal Bank of Canada now owns 19,332 shares of the company’s stock valued at $5,169,000 after buying an additional 5,092 shares during the period. Vident Advisory LLC lifted its holdings in shares of Penumbra by 235.3% in the first quarter. Vident Advisory LLC now owns 2,994 shares of the company’s stock worth $801,000 after buying an additional 2,101 shares in the last quarter. Evergreen Capital Management LLC boosted its position in shares of Penumbra by 13.1% in the first quarter. Evergreen Capital Management LLC now owns 1,065 shares of the company’s stock valued at $285,000 after acquiring an additional 123 shares during the period. Finally, Driehaus Capital Management LLC purchased a new position in Penumbra during the first quarter valued at approximately $20,398,000. Hedge funds and other institutional investors own 88.88% of the company’s stock.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.